...
首页> 外文期刊>British Poultry Science >Pharmacodynamic evaluation of a reference and a generic toltrazuril preparation in broilers experimentally infected with Eimeria tenella or E. acervulina.
【24h】

Pharmacodynamic evaluation of a reference and a generic toltrazuril preparation in broilers experimentally infected with Eimeria tenella or E. acervulina.

机译:在实验感染艾美球虫或小肠埃希氏菌的肉鸡中,对参考品和通用的托他珠利制剂的药效学评价。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to investigate the effects on pigmentation, faecal oocyst output, immune responsiveness and reactive oxygen species (ROS) generation following treatment with either the reference toltrazuril (Baycox) or a generic preparation (gen-TTZ), during an experimental Eimeria tenella (Et) or E. acervulina (Ea) infection of 210 Ross broiler chickens. Results showed a significant difference on the anticoccidial efficacy 6 d after treating infected animals with Baycox (Et: 99.69% and Ea: 99.52%) or gen-TTZ (Et:85.71% and Ea 81.81%). Gen-TTZ-treated animals were less strongly carotenoid-pigmented than Baycox-treated broilers. Mean plasma carotenoid concentrations were significantly higher in groups treated with Baycox than in broilers given gen-TTZ. Treatment of animals with Baycox led to a significant decrease in ability of the peripheral blood mononuclear cells to produce ROS in contrast to gen-TTZ-treated groups. Baycox, but not generic toltrazuril, increased IL-10 and decreased tumour necrosis factor alpha (TNF- alpha ) concentrations in chickens infected with E. tenella and E. acervulina. It is suggested that differences in anticoccidial efficacy may be observed when using a generic toltrazuril product. Hence, in addition to plasma profiles of drugs, standardised clinical control tests may be necessary for generic formulations, particularly if other parameters are important to achieve a better control of coccidiosis.
机译:这项研究的目的是在实验过程中研究使用参考托他珠利(Baycox)或通用制剂(gen-TTZ)处理后对色素沉着,粪便卵囊输出,免疫应答和活性氧(ROS)生成的影响210只Ross肉鸡感染了Eimeria tenella(Et)或E. acervulina(Ea)。结果显示,用Baycox(Et:99.69%和Ea:99.52%)或​​gen-TTZ(Et:85.71%和Ea 81.81%)处理感染的动物后6 d,抗球虫功效显着不同。 Gen-TTZ处理的动物比Baycox处理的肉鸡的类胡萝卜素色素少。用Baycox治疗的组中平均血浆类胡萝卜素浓度显着高于使用gen-TTZ的肉鸡。与gen-TTZ处理组相比,用Baycox处理动物导致外周血单核细胞产生ROS的能力显着降低。在感染了大肠杆菌(E. tenella)和小肠埃希氏菌(E. acervulina)的鸡中,Baycox(但不是通用的托曲唑)增加了IL-10并降低了肿瘤坏死因子α(TNF-α)的浓度。建议在使用通用的托他祖利产品时可能会观察到抗球虫功效的差异。因此,除了药物的血浆谱外,通用制剂可能还需要标准化的临床控制测试,尤其是在其他参数对于更好地控制球虫病很重要的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号